Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.14 +0.59 (+3.60%)

Streaming Delayed Price Updated: 10:49 AM EDT, Jul 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	121,353
Open	16.78
Bid (Size)	17.13 (100)
Ask (Size)	17.16 (500)
Prev. Close	16.55
Today's Range	16.54 - 17.15
52wk Range	12.72 - 18.91
Shares Outstanding	353,800,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence

July 01, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Small-Cap Stocks We Steer Clear Of

June 30, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

Performance

YTD	+3.4%	+3.4%
1 Month	+11.4%	+11.4%
3 Month	+2.8%	+2.8%
6 Month	+0.4%	+0.4%
1 Year	+27.5%	+27.5%

More News

1 Stock Under $50 to Own for Decades and 2 We Turn Down

June 25, 2026

Via StockStory

Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

June 01, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Corp (NYSE:BLCO) Beats Q1 Estimates, Raises Full-Year Guidance ↗

April 29, 2026

Via Chartmill

Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 21, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results

May 20, 2026

From Bausch + Lomb Corporation

Via Business Wire

Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest

May 19, 2026

Via StockStory

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

May 19, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Profitable Stocks We’re Skeptical Of

May 18, 2026

Via StockStory

Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

May 07, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second R&D “Teach-in” Webinar

May 06, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript ↗

April 30, 2026

Via The Motley Fool

Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting

April 30, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

April 29, 2026

Via StockStory

Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

April 29, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For

April 27, 2026

Via StockStory

Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration

April 23, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Releases 2025 Sustainability Impact Report

April 22, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch Lomb BLCO Q2 2025 Earnings Transcript ↗

April 21, 2026

Via The Motley Fool

Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript ↗

April 21, 2026

Via The Motley Fool

Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript ↗

April 21, 2026

Via The Motley Fool

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program

April 16, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Cash-Burning Stocks We Keep Off Our Radar

April 10, 2026

Via StockStory

Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update

April 08, 2026

From Bausch + Lomb Corporation

Via Business Wire

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?

Yes, Bausch + Lomb Corporation Common Shares is publicly traded.

What exchange does Bausch + Lomb Corporation Common Shares trade on?

Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange

What is the ticker symbol for Bausch + Lomb Corporation Common Shares?

The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange

What is the current price of Bausch + Lomb Corporation Common Shares?

The current price of Bausch + Lomb Corporation Common Shares is 17.14

When was Bausch + Lomb Corporation Common Shares last traded?

The last trade of Bausch + Lomb Corporation Common Shares was at 07/02/26 10:49 AM ET

What is the market capitalization of Bausch + Lomb Corporation Common Shares?

The market capitalization of Bausch + Lomb Corporation Common Shares is 6.07B

How many shares of Bausch + Lomb Corporation Common Shares are outstanding?

Bausch + Lomb Corporation Common Shares has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.